CAR-T & Cell Therapy— Companies & Signals
CAR-T and cell therapies represent a paradigm shift in oncology, engineering a patient's own cells to precisely target and eliminate cancer. This innovative approach offers the potential for durable remissions and cures in previously intractable hematological malignancies and is rapidly expanding into solid tumors, presenting a significant growth opportunity in the biopharmaceutical sector. 72 public companies above the $50M floor. Last 90 days: 37 red 8-Ks, 0 insider cluster-buys, 9 running hot in the press.
72
Companies
37
Red 8-Ks · 90d
0
Insider clusters
9
🔥 Media-hot
Companies in CAR-T & Cell Therapy
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IMMX | Immix Biopharma, Inc. | Healthcare | $601.6M | +5.1% | +11.6% | 1.9M | — | |
| 2 | PGEN | PRECIGEN, INC. | Healthcare | $1.6B | +1.0% | +10.0% | 6.3M | — | red 8-K |
| 3 | AUTL | Autolus Therapeutics plc | Healthcare | $415.2M | +2.5% | +10.7% | 960K | — | red 8-K |
| 4 | CRBU | Caribou Biosciences, Inc. | Healthcare | $158.2M | +5.4% | +7.9% | 2.8M | — | |
| 5 | ANIX | Anixa Biosciences Inc | Healthcare | $84.0M | +2.1% | +2.9% | 429K | — | |
| 6 | CLYM | Climb Bio, Inc. | Healthcare | $655.1M | +2.1% | +9.7% | 1.2M | — | red 8-K |
| 7 | NKTX | Nkarta, Inc. | Healthcare | $204.6M | +0.7% | +2.1% | 577K | — | |
| 8 | RNAC | Cartesian Therapeutics, Inc. | Healthcare | $279.4M | +2.3% | -3.1% | 192K | — | red 8-K |
| 9 | LEGN | Legend Biotech Corp | Healthcare | $6.7B | +2.4% | +0.2% | 1.3M | ⚡ | |
| 10 | ZSQR | Z Squared Inc. | Financials | $561.9M | -6.3% | -20.7% | 671K | — | red 8-K |
| 11 | LYEL | Lyell Immunopharma, Inc. | Healthcare | $315.0M | +9.8% | +6.5% | 200K | — | |
| 12 | CABA | Cabaletta Bio, Inc. | Healthcare | $490.8M | +2.3% | +3.3% | 5.5M | — | |
| 13 | REPL | Replimune Group, Inc. | Healthcare | $733.2M | -3.7% | +0.2% | 3.7M | — | |
| 14 | MXCT | MAXCYTE, INC. | Healthcare | $120.0M | 0.0% | +5.1% | 1.2M | — | red 8-K |
| 15 | ELTX | Elicio Therapeutics, Inc. | Healthcare | $283.4M | 0.0% | -3.4% | 456K | — | |
| 16 | NTLA | Intellia Therapeutics, Inc. | Healthcare | $1.7B | -0.4% | +5.5% | 5.6M | ⚡ | |
| 17 | FATE | FATE THERAPEUTICS INC | Healthcare | $240.1M | +15.2% | +12.6% | 5.9M | — | red 8-K |
| 18 | ALLO | Allogene Therapeutics, Inc. | Healthcare | $655.8M | +4.2% | +5.7% | 14.7M | — | red 8-K |
| 19 | JANX | Janux Therapeutics, Inc. | Healthcare | $826.9M | +2.6% | +6.9% | 1.2M | — | red 8-K |
| 20 | SANA | Sana Biotechnology, Inc. | Healthcare | $745.8M | +0.9% | +2.7% | 2.5M | — | red 8-K |
| 21 | AZN | ASTRAZENECA PLC | Healthcare | $277.2B | +1.4% | +8.2% | 1.6M | 🔥 | |
| 22 | CCCC | C4 Therapeutics, Inc. | Healthcare | $431.2M | +2.1% | +5.6% | 3.1M | — | red 8-K |
| 23 | CRSP | CRISPR Therapeutics AG | Healthcare | $4.9B | +2.6% | +3.7% | 1.8M | ⚡ | red 8-K |
| 24 | IBIO | iBio, Inc. | Healthcare | $84.0M | +3.6% | -0.6% | 1.1M | — | red 8-K |
| 25 | INDP | Indaptus Therapeutics, Inc. | Healthcare | $405.4M | -10.3% | -18.9% | 223K | — | red 8-K |
| 26 | IPSC | Century Therapeutics, Inc. | Healthcare | $405.8M | +3.9% | +4.8% | 1.9M | — | red 8-K |
| 27 | GLSI | Greenwich LifeSciences, Inc. | Healthcare | $353.2M | +17.4% | -2.1% | 208K | — | |
| 28 | GILD | GILEAD SCIENCES, INC. | Healthcare | $155.9B | -1.2% | +1.2% | 6.9M | 🔥 | |
| 29 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Healthcare | $1.8B | -0.9% | +3.7% | 10.7M | — | |
| 30 | CDNA | CareDx, Inc. | Healthcare | $1.2B | +1.6% | +16.9% | 498K | — | red 8-K |
| 31 | JNJ | JOHNSON & JOHNSON | Healthcare | $579.8B | +1.5% | +11.8% | 8.6M | 🔥 | |
| 32 | COYA | Coya Therapeutics, Inc. | Healthcare | $111.2M | +10.4% | +14.7% | 293K | — | red 8-K |
| 33 | ACET | Adicet Bio, Inc. | Healthcare | $75.3M | +2.3% | +4.0% | 74K | — | |
| 34 | CUE | Cue Biopharma, Inc. | Healthcare | $103.0M | +19.9% | -1.0% | 164K | — | red 8-K |
| 35 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | $489.7M | +4.0% | +5.8% | 1.4M | — | red 8-K |
| 36 | HURA | TuHURA Biosciences, Inc./NV | Healthcare | $147.7M | +6.0% | -15.5% | 794K | — | red 8-K |
| 37 | XNCR | Xencor Inc | Healthcare | $914.2M | +3.6% | +11.3% | 750K | — | red 8-K |
| 38 | WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $205.7M | +6.0% | -1.1% | 364K | — | |
| 39 | ZBIO | Zenas BioPharma, Inc. | Healthcare | $1.3B | -1.2% | +22.8% | 1.7M | — | red 8-K |
| 40 | MGTX | MeiraGTx Holdings plc | Healthcare | $888.1M | +3.5% | +9.2% | 683K | — | |
| 41 | EDIT | Editas Medicine, Inc. | Healthcare | $383.7M | +12.3% | +14.3% | 3.0M | — | red 8-K |
| 42 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $1.8B | +4.2% | +27.9% | 2.7M | 🔥 | |
| 43 | TIL | Instil Bio, Inc. | Healthcare | $53.7M | +1.4% | -0.4% | 17K | — | red 8-K |
| 44 | MRNA | Moderna, Inc. | Healthcare | $19.8B | +3.6% | +17.4% | 8.1M | 🔥 | |
| 45 | RVTY | REVVITY, INC. | Healthcare | $11.1B | -1.6% | +12.3% | 2.0M | 🔥 | |
| 46 | KNSA | Kiniksa Pharmaceuticals International, plc | Healthcare | $4.0B | +5.4% | +9.2% | 1.5M | — | red 8-K |
| 47 | EDSA | Edesa Biotech, Inc. | Healthcare | $51.6M | -6.3% | +12.6% | 75K | — | red 8-K |
| 48 | CYRX | Cryoport, Inc. | Healthcare | $736.9M | +1.8% | +10.2% | 965K | — | |
| 49 | CAPR | CAPRICOR THERAPEUTICS, INC. | Healthcare | $1.5B | -10.0% | -18.9% | 3.2M | — | |
| 50 | NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.0B | +2.7% | -0.5% | 1.2M | — | red 8-K |
| 51 | DTIL | PRECISION BIOSCIENCES INC | Healthcare | $157.4M | +8.6% | +11.9% | 775K | — | red 8-K |
| 52 | AGPU | Axe Compute Inc. | Financials | $76.9M | +5.3% | +5.6% | 215K | — | red 8-K |
| 53 | CADL | Candel Therapeutics, Inc. | Healthcare | $627.2M | +5.8% | +13.2% | 1.5M | — | red 8-K |
| 54 | OCGN | Ocugen, Inc. | Healthcare | $409.6M | +11.3% | +29.5% | 14.2M | 🔥 | red 8-K |
| 55 | VTVT | vTv Therapeutics Inc. | Healthcare | $129.0M | +3.4% | +6.9% | 80K | — | |
| 56 | SYRE | Spyre Therapeutics, Inc. | Healthcare | $7.0B | +2.6% | -10.1% | 2.0M | — | red 8-K |
| 57 | CAI | Caris Life Sciences, Inc. | Healthcare | $5.1B | -1.0% | +5.8% | 3.8M | — | |
| 58 | PROK | PROKIDNEY CORP. | Healthcare | $336.5M | +3.3% | +3.9% | 1.4M | — | |
| 59 | ABBV | AbbVie Inc. | Healthcare | $402.4B | +0.4% | +10.6% | 9.8M | 🔥 | |
| 60 | CLLS | Cellectis S.A. | Healthcare | $310.9M | +3.9% | +4.3% | 22K | — |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.